My Health Everyday App
Product and provider description
Target populations
Target condition & treatment
Adherence monitoring
Adherence support
Development and evaluation
Product and provider description
Brand name:
Moje zdrowie na co dzień
Moje zdrowie na co dzień
Full name:
My Health Everyday application
My Health Everyday application
Brief description:
The health application ‘My Health Everyday’ (Polish: ‘Moje zdrowie na co dzien’) was officially launched on May 17, 2022. It was developed as part of the GATEKEEPER program by researchers from the Medication Adherence Research Center at the Medical University of Lodz, Poland. This app supports patients in the systematic management of their chronic conditions, especially asymptomatic ones. Importantly, it provides specific solutions when difficulties in adhering to treatment arise, helping users take better care of their health and achieve improved treatment outcomes. The researchers aimed to enhance older adults awareness of the importance of treatment adherence and developed solutions to reduce polypharmacy, a serious issue among older adults. With the support of the GATEKEEPER project, their achievements became accessible to every senior for free, facilitating better management of multi-drug regimens. The application has been extensively studied in a clinical study in over 500 users in Poland. Furthermore, thanks to additional support from the GATEKEEPER TWINNING project, the application was tested and implemented in Hungary.
The health application ‘My Health Everyday’ (Polish: ‘Moje zdrowie na co dzien’) was officially launched on May 17, 2022. It was developed as part of the GATEKEEPER program by researchers from the Medication Adherence Research Center at the Medical University of Lodz, Poland. This app supports patients in the systematic management of their chronic conditions, especially asymptomatic ones. Importantly, it provides specific solutions when difficulties in adhering to treatment arise, helping users take better care of their health and achieve improved treatment outcomes. The researchers aimed to enhance older adults awareness of the importance of treatment adherence and developed solutions to reduce polypharmacy, a serious issue among older adults. With the support of the GATEKEEPER project, their achievements became accessible to every senior for free, facilitating better management of multi-drug regimens. The application has been extensively studied in a clinical study in over 500 users in Poland. Furthermore, thanks to additional support from the GATEKEEPER TWINNING project, the application was tested and implemented in Hungary.
Technology Readiness Level:
TRL 7: Demonstration system
TRL 7: Demonstration system
Date first available:
2022-05-17
2022-05-17
Date latest update:
2022-05-17
2022-05-17
Current version identifier:
v.1
v.1
Types of components:
Software
Software
Is the technology designed to be used as stand-alone or/and as component of a larger solution:
As a stand-alone solution
As a stand-alone solution
Languages:
Hungarian, Polish
Hungarian, Polish
Countries:
Hungary, Poland
Hungary, Poland
Do any terms and conditions apply?
No
No
Is the technology free of charge or a fee is required for its use?
Free
Free
Provider name:
Medical University of Lodz
Medical University of Lodz
Provider type:
Public or state-owned organisation
Public or state-owned organisation
Provider domain of activity:
Healthcare, Research and/or education
Healthcare, Research and/or education
Please contact the provider at:
agnieszka.lesniak@umed.lodz.pl
agnieszka.lesniak@umed.lodz.pl
Target populations
Is the MATech intended to be used for self-management?
Yes
Yes
Who interacts with the MATech for self-management?
Patient, Caregiver
Patient, Caregiver
The MATech is intended to be used by one or more persons?
No information available
No information available
Patient age group(s) the MATech is suitable for:
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old, Adolescents – 12 – 17 years
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old, Adolescents – 12 – 17 years
Level of functioning in memory functions the MATech is suitable for:
mild impairment
mild impairment
Level of functioning in perception functions the MATech is suitable for:
mild impairment
mild impairment
Level of functioning in visual functions the MATech is suitable for:
no impairment
no impairment
Level of functioning in auditive functions the MATech is suitable for:
complete impairment
complete impairment
Level of functioning in movement & mobility the MATech is suitable for:
moderate impairment
moderate impairment
Is the MATech suitable for patients with low literacy (ability to read and write)?
No information available
No information available
Is the MATech suitable for patients with low health literacy (capacity to obtain, process and understand basic health information and services)?
No information available
No information available
Is the MATech suitable for patients with comorbidity?
No information available
No information available
Is the MATech suitable for patients with limited experience with technologies?
No information available
No information available
Is the MATech intended to be used for within an adherence support service?
Yes
Yes
Is the MATech intended to be used by health or social care providers?
Yes
Yes
Is the MATech intended to be used by administrators or health system managers?
No information available
No information available
Target condition & treatment
Target health condition domains for which the MATech is designed:
Blood, Cancer and neoplasms, Cardiovascular, Congenital disorder, Ear, Eye, Infection, Inflammatory and immune system, Mental health, Metabolic and endocrine, Musculoskeletal, Neurological, Oral and gastrointestinal, Renal and urogenital, Reproductive health and childbirth, Respiratory, Skin, Stroke, Generic health relevance
Blood, Cancer and neoplasms, Cardiovascular, Congenital disorder, Ear, Eye, Infection, Inflammatory and immune system, Mental health, Metabolic and endocrine, Musculoskeletal, Neurological, Oral and gastrointestinal, Renal and urogenital, Reproductive health and childbirth, Respiratory, Skin, Stroke, Generic health relevance
The MATech is suitable for medication prescribed:
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
The MATech is suitable for (treatment duration):
No information available
No information available
The MATech is suitable for (administration form):
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
The MATech is suitable for (single/polypharmacy):
Single drug treatments, Polypharmacy (combination therapies)
Single drug treatments, Polypharmacy (combination therapies)
The MATech is suitable for (dosage instructions):
Once-daily doses
Once-daily doses
The MATech is designed to be used for adherence monitoring or intervention:
Monitor/measure medication adherence, Intervene to support medication adherence
Monitor/measure medication adherence, Intervene to support medication adherence
Brief description:
A questionnaire asks patient for their adherece, in case of non-adherence, tailored solutions are proposed.
A questionnaire asks patient for their adherece, in case of non-adherence, tailored solutions are proposed.
The MATech is designed to be used in (adherence phases):
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Adherence monitoring
Methods used by the MATech to measure adherence:
Self-report
Self-report
Behavioral aspects targeted by the MATech measurement component:
determinants of behaviour, behaviour itself, outcomes
determinants of behaviour, behaviour itself, outcomes
Behaviors targeted by the MATech measurement component:
medication adherence
medication adherence
Outcomes targeted by the MATech measurement component:
clinical (e.g. morbidity, mortality), humanistic (e.g. health-related quality of life, satisfaction)
clinical (e.g. morbidity, mortality), humanistic (e.g. health-related quality of life, satisfaction)
Adherence support
Modes of delivering adherence support used in the technology:
No information available
No information available
Printed material formats used:
No information available
No information available
Human interaction formats used:
No information available
No information available
Electronic formats used:
Use of a smartphone or tablet
Use of a smartphone or tablet
Smartphone/tablet formats used:
app (application)
app (application)
App features included:
it is interactive, includes diaries
it is interactive, includes diaries
Wearable device formats used:
No information available
No information available
Digital media formats used:
No information available
No information available
Behaviour change content of the intervention (e.g. what adherence barriers and facilitators are targeted, what behaviour change techniques it includes):
In cased of non-adherence, technology helps to identify the reason, and find a solution to it.
In cased of non-adherence, technology helps to identify the reason, and find a solution to it.
Types of intervention providers involved (i.e. persons using the technology to support patients manage adherence):
Medical doctor (Generalist medical practitioner, Specialist medical practitioner), Nursing professional, Midwifery professional, Pharmacist (Community pharmacist, Hospital pharmacist), Dentist, Associated health professional (Community healthcare worker, Healthcare assistant), Personal care worker, Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Carer, Friend, Peer
Medical doctor (Generalist medical practitioner, Specialist medical practitioner), Nursing professional, Midwifery professional, Pharmacist (Community pharmacist, Hospital pharmacist), Dentist, Associated health professional (Community healthcare worker, Healthcare assistant), Personal care worker, Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Carer, Friend, Peer
Types of intervention setting (i.e. where the technology is designed to be used for supporting adherence):
Household residence, Doctor-led primary care facility, Care home facility, Hospice facility, Pharmacy facility, Psychiatric facility, Community healthcare facility, Dentist facility, Educational facility, Social centre or Community Hall facility
Household residence, Doctor-led primary care facility, Care home facility, Hospice facility, Pharmacy facility, Psychiatric facility, Community healthcare facility, Dentist facility, Educational facility, Social centre or Community Hall facility
Telehealth environments applicable:
Telemedicine, Telepharmacy
Telemedicine, Telepharmacy
Development and evaluation
Brief description of how the technology has been developed and evaluated (e.g. transparency, theory and evidence base, context compatibility, co-creation, scientific evaluation, etc.):
Technology has been designed by experts in medication adherence, fine-tuned in a pilot in limited number of patients, and validated in a large study in >500 individuals.
Technology has been designed by experts in medication adherence, fine-tuned in a pilot in limited number of patients, and validated in a large study in >500 individuals.
Matech Disclaimer
ENABLE – COST Action CA19132 (ENABLE) maintains this website to enhance public access to our online repository where interested parties would be able to search for medication adherence technologies and learn about them for their research or practice.
Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However, ENABLE accepts no responsibility or liability whatsoever with regard to the information on this site.